Published in J Am Acad Dermatol on June 19, 2010
Transcriptome-wide studies of merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival. J Clin Oncol (2011) 2.52
PD-L1 expression in the Merkel cell carcinoma microenvironment: association with inflammation, Merkel cell polyomavirus and overall survival. Cancer Immunol Res (2013) 2.30
Vascular E-selectin expression correlates with CD8 lymphocyte infiltration and improved outcome in Merkel cell carcinoma. J Invest Dermatol (2013) 1.58
Both tumor depth and diameter are predictive of sentinel lymph node status and survival in Merkel cell carcinoma. Cancer (2015) 1.43
Age-specific seroprevalence of Merkel cell polyomavirus, BK virus, and JC virus. Clin Vaccine Immunol (2011) 1.35
Systemic immune suppression predicts diminished Merkel cell carcinoma-specific survival independent of stage. J Invest Dermatol (2012) 1.30
Merkel polyomavirus-specific T cells fluctuate with merkel cell carcinoma burden and express therapeutically targetable PD-1 and Tim-3 exhaustion markers. Clin Cancer Res (2013) 1.22
Recurrence and survival in patients undergoing sentinel lymph node biopsy for merkel cell carcinoma: analysis of 153 patients from a single institution. Ann Surg Oncol (2011) 1.14
Immunobiology of Merkel cell carcinoma: implications for immunotherapy of a polyomavirus-associated cancer. Curr Oncol Rep (2011) 1.03
Merkel cell polyomavirus small T antigen is oncogenic in transgenic mice. J Invest Dermatol (2014) 1.03
Emerging and mechanism-based therapies for recurrent or metastatic Merkel cell carcinoma. Curr Treat Options Oncol (2013) 1.03
Histological, immunohistological, and clinical features of merkel cell carcinoma in correlation to merkel cell polyomavirus status. J Skin Cancer (2012) 0.96
Effect of host, tumor, diagnostic, and treatment variables on outcomes in a large cohort with Merkel cell carcinoma. JAMA Dermatol (2014) 0.94
T-cell responses to oncogenic merkel cell polyomavirus proteins distinguish patients with merkel cell carcinoma from healthy donors. Clin Cancer Res (2014) 0.94
Pathologic nodal evaluation is increasingly commonly performed for patients with Merkel cell carcinoma. J Am Acad Dermatol (2013) 0.92
A practical update of surgical management of merkel cell carcinoma of the skin. ISRN Surg (2013) 0.89
A review of the epidemiology and treatment of Merkel cell carcinoma. Clinics (Sao Paulo) (2011) 0.89
Merkel cell carcinoma: chemotherapy and emerging new therapeutic options. J Skin Cancer (2013) 0.86
Detection of Merkel cell virus and correlation with histologic presence of Merkel cell carcinoma in sentinel lymph nodes. Br J Cancer (2012) 0.86
Relationships among primary tumor size, number of involved nodes, and survival for 8044 cases of Merkel cell carcinoma. J Am Acad Dermatol (2014) 0.85
Sentinel lymph node biopsy in nonmelanoma skin cancer patients. J Skin Cancer (2013) 0.84
Downregulation of MHC-I expression is prevalent but reversible in Merkel cell carcinoma. Cancer Immunol Res (2014) 0.84
CD8+ lymphocyte intratumoral infiltration as a stage-independent predictor of Merkel cell carcinoma survival: a population-based study. Am J Clin Pathol (2014) 0.83
p63 expression in Merkel cell carcinoma predicts poorer survival yet may have limited clinical utility. Am J Clin Pathol (2013) 0.83
Role of sentinel lymph node biopsy in patients with Merkel cell carcinoma: statistical analysis of 403 reported cases. Int J Clin Oncol (2014) 0.83
Milestones in the staging, classification, and biology of Merkel cell carcinoma. J Natl Compr Canc Netw (2014) 0.82
Merkel cell carcinoma: a review and update on aetiopathogenesis, diagnosis and treatment approaches. Wien Med Wochenschr (2013) 0.82
Somatostatin receptor expression in Merkel cell carcinoma as target for molecular imaging. BMC Cancer (2014) 0.81
A unique case of merkel cell carcinoma with ovarian metastasis. Balkan Med J (2014) 0.81
Merkel cell carcinoma of the eyelid and periocular region. Cancers (Basel) (2014) 0.80
How does the Merkel polyomavirus lead to a lethal cancer? Many answers, many questions, and a new mouse model. J Invest Dermatol (2015) 0.80
Inflammatory cell distribution in primary merkel cell carcinoma. Cancers (Basel) (2014) 0.80
[Merkel cell carcinoma]. Pathologe (2014) 0.80
Response rates and durability of chemotherapy among 62 patients with metastatic Merkel cell carcinoma. Cancer Med (2016) 0.80
Merkel cell carcinoma of the head and neck: pathogenesis, current and emerging treatment options. Onco Targets Ther (2015) 0.79
Diagnostic biopsy does not commonly induce intratumoral CD8 T cell infiltration in Merkel cell carcinoma. PLoS One (2012) 0.79
Clinical utility of a circulating tumor cell assay in Merkel cell carcinoma. J Am Acad Dermatol (2013) 0.79
Evaluating blood levels of neuron specific enolase, chromogranin A, and circulating tumor cells as Merkel cell carcinoma biomarkers. Oncotarget (2015) 0.78
Systemic Therapy for Merkel Cell Carcinoma: What's on the Horizon? Cancers (Basel) (2014) 0.77
Merkel cell carcinoma of the head and neck: a single institutional experience. J Skin Cancer (2013) 0.77
Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2016 MauiDerm Meeting based on presentations by. J Clin Aesthet Dermatol (2016) 0.77
Response to Anti-PD-1 Therapy in Metastatic Merkel Cell Carcinoma Metastatic to the Heart and Pancreas. Cureus (2015) 0.77
Polyomavirus-negative Merkel cell carcinoma: a more aggressive subtype based on analysis of 282 cases using multi-modal tumor virus detection. J Invest Dermatol (2016) 0.77
Tumor-Infiltrating Merkel Cell Polyomavirus-Specific T Cells Are Diverse and Associated with Improved Patient Survival. Cancer Immunol Res (2017) 0.76
Prokineticins and Merkel cell polyomavirus infection in Merkel cell carcinoma. Br J Cancer (2014) 0.76
Detection of mitotic figures and G2+ tumor nuclei with histone markers correlates with worse overall survival in patients with Merkel cell carcinoma. J Cutan Pathol (2014) 0.76
Merkel Cell Carcinoma Analysis of Outcomes: A 30-Year Experience. PLoS One (2015) 0.75
Single-fraction radiation therapy in patients with metastatic Merkel cell carcinoma. Cancer Med (2015) 0.75
Histological pattern of Merkel cell carcinoma sentinel lymph node metastasis improves stratification of Stage III patients. Mod Pathol (2015) 0.75
Reversal of epigenetic silencing of MHC class I chain-related protein A and B improves immune recognition of Merkel cell carcinoma. Sci Rep (2016) 0.75
Merkel Cell Carcinoma. Surg Pathol Clin (2017) 0.75
Radiation therapy in the management of Merkel cell carcinoma: current perspectives. Expert Rev Dermatol (2011) 0.75
Nuclear medicine techniques in Merkel cell carcinoma: A case report and review of the literature. Oncol Lett (2015) 0.75
Complete spontaneous regression of merkel cell carcinoma. Glob Adv Health Med (2013) 0.75
Merkel cell polyomavirus infection and Merkel cell carcinoma. Curr Opin Virol (2016) 0.75
Clinical features and treatment of vulvar Merkel cell carcinoma: a systematic review. Gynecol Oncol Res Pract (2017) 0.75
Merkel Cell Carcinoma of the Hand: A Case Report and Review of the Literature. Hand (N Y) (2016) 0.75
Anaemia due to gastric haemorrhage by a metastatic Merkel cell carcinoma. Prz Gastroenterol (2015) 0.75
Merkel cell carcinoma with partial B-cell blastic immunophenotype: a potential mimic of cutaneous richter transformation in a patient with chronic lymphocytic lymphoma. Am J Dermatopathol (2014) 0.75
Merkel cell carcinoma occurring in a black woman: a case report. J Med Case Rep (2017) 0.75
Merkel cell carcinoma in organ transplant recipients: Case reports and review of the literature. JAAD Case Rep (2015) 0.75
[Merkel cell carcinoma of the eyelid. An often unrecognized tumor entity : Clinical aspects and treatment strategies]. Ophthalmologe (2017) 0.75
A case series and literature review of Merkel cell carcinoma metastasizing to pancreas. Dig Dis Sci (2015) 0.75
Sentinel lymph node biopsy in periocular merkel cell carcinoma: a case report. BMC Res Notes (2017) 0.75
Is this the end of cytotoxic chemotherapy in Merkel cell carcinoma? Onco Targets Ther (2017) 0.75
Preclinical evaluation of NF-κB-triggered dendritic cells expressing the viral oncogenic driver of Merkel cell carcinoma for therapeutic vaccination. Ther Adv Med Oncol (2017) 0.75
Merkel Cell Carcinoma of the Head and Neck: Recommendations for Diagnostics and Treatment. Ann Surg Oncol (2017) 0.75
Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science (2008) 16.60
Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol (2001) 10.20
Regression models for relative survival. Stat Med (2004) 5.40
Merkel cell carcinoma: prognosis and treatment of patients from a single institution. J Clin Oncol (2005) 4.79
Merkel cell carcinoma and HIV infection. Lancet (2002) 4.72
Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features. J Am Acad Dermatol (2008) 4.69
The National Cancer Data Base: a powerful initiative to improve cancer care in the United States. Ann Surg Oncol (2008) 3.82
Merkel cell carcinoma: changing incidence trends. J Surg Oncol (2005) 3.78
Sentinel lymph node biopsy for evaluation and treatment of patients with Merkel cell carcinoma: The Dana-Farber experience and meta-analysis of the literature. Arch Dermatol (2006) 2.92
Merkel cell carcinoma: more deaths but still no pathway to blame. J Invest Dermatol (2007) 2.72
Merkel cell carcinoma demographics, morphology, and survival based on 3870 cases: a population based study. J Cutan Pathol (2009) 2.63
Epidemiology of primary Merkel cell carcinoma in the United States. J Am Acad Dermatol (2003) 2.56
Merkel cell carcinoma. Prognosis and management. Arch Surg (1991) 1.72
Merkel cell carcinoma: histologic features and prognosis. Cancer (2008) 1.50
A model for predicting non-sentinel lymph node metastatic disease when the sentinel lymph node is positive. Br J Surg (2008) 1.40
A worldwide approach to the TNM staging system: collaborative efforts of the AJCC and UICC. J Surg Oncol (2009) 1.25
Surgical management of Merkel cell carcinoma. Ann Surg (1999) 1.21
TNM: principles, history, and relation to other prognostic factors. Cancer (2001) 1.14
Nomograms as predictive models. Semin Urol Oncol (2002) 1.11
Merkel cell carcinoma of the head and neck: is adjuvant radiotherapy necessary? Head Neck (2007) 1.10
Protocol for the examination of specimens from patients with merkel cell carcinoma of the skin. Arch Pathol Lab Med (2010) 1.04
Toward better management of merkel cell carcinoma using a consensus staging system, new diagnostic codes and a recently discovered virus. Actas Dermosifiliogr (2009) 0.88
Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol (2009) 23.08
Efficient tumour formation by single human melanoma cells. Nature (2008) 16.35
A landscape of driver mutations in melanoma. Cell (2012) 12.61
Management of cutaneous melanoma. N Engl J Med (2004) 9.52
Meta-analysis of phase II cooperative group trials in metastatic stage IV melanoma to determine progression-free and overall survival benchmarks for future phase II trials. J Clin Oncol (2008) 8.09
Exome sequencing identifies GRIN2A as frequently mutated in melanoma. Nat Genet (2011) 7.31
Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years. JAMA (2005) 5.52
Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma. Nat Med (2010) 4.81
PTEN loss confers BRAF inhibitor resistance to melanoma cells through the suppression of BIM expression. Cancer Res (2011) 4.80
ATR regulates fragile site stability. Cell (2002) 4.74
Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features. J Am Acad Dermatol (2008) 4.69
Sentinel node biopsy and standard of care for melanoma. J Am Acad Dermatol (2009) 4.32
Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized. Cancer Cell (2010) 3.70
Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. JAMA (2013) 3.38
Skin cancer in organ transplant recipients: Epidemiology, pathogenesis, and management. J Am Acad Dermatol (2002) 3.20
Sentinel-lymph-node biopsy for cutaneous melanoma. N Engl J Med (2011) 3.10
Adjuvant immunotherapy of resected, intermediate-thickness, node-negative melanoma with an allogeneic tumor vaccine: impact of HLA class I antigen expression on outcome. J Clin Oncol (2002) 3.05
Primary cilia can both mediate and suppress Hedgehog pathway-dependent tumorigenesis. Nat Med (2009) 2.99
Five-year follow-up of patients with advanced chronic lymphocytic leukemia treated with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning. J Clin Oncol (2008) 2.99
Sentinel lymph node biopsy for evaluation and treatment of patients with Merkel cell carcinoma: The Dana-Farber experience and meta-analysis of the literature. Arch Dermatol (2006) 2.92
Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma. J Clin Oncol (2008) 2.88
Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and an intact primary tumor. Ann Surg Oncol (2006) 2.84
Merkel cell polyomavirus is more frequently present in North American than Australian Merkel cell carcinoma tumors. J Invest Dermatol (2008) 2.80
Merkel cell carcinoma: more deaths but still no pathway to blame. J Invest Dermatol (2007) 2.72
Activation of stat3 in human melanoma promotes brain metastasis. Cancer Res (2006) 2.70
NRAS mutation status is an independent prognostic factor in metastatic melanoma. Cancer (2011) 2.69
Comorbidity and disease status based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic cell transplantation. J Clin Oncol (2007) 2.66
Melanoma information on the Internet: often incomplete--a public health opportunity? J Clin Oncol (2002) 2.61
Exon capture analysis of G protein-coupled receptors identifies activating mutations in GRM3 in melanoma. Nat Genet (2011) 2.60
Randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone compared with melphalan plus tumor necrosis factor: American College of Surgeons Oncology Group Trial Z0020. J Clin Oncol (2006) 2.60
Anti-oncogenic role of the endoplasmic reticulum differentially activated by mutations in the MAPK pathway. Nat Cell Biol (2006) 2.58
Breast cancer on the world wide web: cross sectional survey of quality of information and popularity of websites. BMJ (2002) 2.53
Transcriptome-wide studies of merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival. J Clin Oncol (2011) 2.52
Long-term complications associated with breast-conservation surgery and radiotherapy. Ann Surg Oncol (2002) 2.51
Relapse risk in patients with malignant diseases given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning. Blood (2007) 2.49
Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD. Blood (2009) 2.44
Mitotic rate and younger age are predictors of sentinel lymph node positivity: lessons learned from the generation of a probabilistic model. Ann Surg Oncol (2004) 2.42
The risk of in-transit melanoma metastasis depends on tumor biology and not the surgical approach to regional lymph nodes. J Clin Oncol (2005) 2.41
Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. J Clin Oncol (2005) 2.41
Temporal dissection of tumorigenesis in primary cancers. Cancer Discov (2011) 2.40
Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes. Blood (2008) 2.39
The HSP90 inhibitor XL888 overcomes BRAF inhibitor resistance mediated through diverse mechanisms. Clin Cancer Res (2012) 2.31
Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases. J Clin Oncol (2010) 2.30
Integration of growth factor and nutrient signaling: implications for cancer biology. Mol Cell (2003) 2.29
Long-term efficacy of sigmoidoscopy in the reduction of colorectal cancer incidence. J Natl Cancer Inst (2003) 2.29
Positive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapy. Cancer (2003) 2.29
Allogeneic hematopoietic cell transplantation after fludarabine and 2 Gy total body irradiation for relapsed and refractory mantle cell lymphoma. Blood (2004) 2.28
Genome-wide association study identifies novel loci predisposing to cutaneous melanoma. Hum Mol Genet (2011) 2.26
Activation of the ATR-mediated DNA damage response by the HIV-1 viral protein R. J Biol Chem (2003) 2.26
In-transit melanoma: an individualized approach. Oncology (Williston Park) (2011) 2.24
Significance of minimal residual disease before myeloablative allogeneic hematopoietic cell transplantation for AML in first and second complete remission. Blood (2013) 2.23
Cutaneous angiosarcoma of the scalp: a multidisciplinary approach. Cancer (2003) 2.23
Validation of a breast cancer nomogram for predicting nonsentinel lymph node metastases after a positive sentinel node biopsy. Ann Surg Oncol (2006) 2.23
Congenital melanocytic nevi: clinical and histopathologic features, risk of melanoma, and clinical management. J Am Acad Dermatol (2005) 2.22
Association of Merkel cell polyomavirus-specific antibodies with Merkel cell carcinoma. J Natl Cancer Inst (2009) 2.22
Integrated Molecular and Clinical Analysis of AKT Activation in Metastatic Melanoma. Clin Cancer Res (2009) 2.21
An evidence-based staging system for cutaneous melanoma. CA Cancer J Clin (2004) 2.18
Correlation between prognostic factors and increasing age in melanoma. Ann Surg Oncol (2004) 2.18
Lymphovascular invasion and lobular histology are associated with increased incidence of isolated tumor cells in sentinel lymph nodes from early-stage breast cancer patients. Ann Surg Oncol (2008) 2.17
Comparison of outcomes of HLA-matched related, unrelated, or HLA-haploidentical related hematopoietic cell transplantation following nonmyeloablative conditioning for relapsed or refractory Hodgkin lymphoma. Biol Blood Marrow Transplant (2008) 2.15
Antibodies to merkel cell polyomavirus T antigen oncoproteins reflect tumor burden in merkel cell carcinoma patients. Cancer Res (2010) 2.14
The role of sentinel lymph node biopsy for melanoma: evidence assessment. J Am Acad Dermatol (2005) 2.12
Late effects of hematopoietic cell transplantation among 10-year adult survivors compared with case-matched controls. J Clin Oncol (2005) 2.11
Surgical management of melanoma-in-situ using a staged marginal and central excision technique. Ann Surg Oncol (2008) 2.11
Electrosurgery and implantable electronic devices: review and implications for office-based procedures. Dermatol Surg (2011) 2.07
Nonmyeloablative allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia. J Clin Oncol (2010) 2.07
Hematopoietic cell transplantation after nonmyeloablative conditioning for advanced chronic lymphocytic leukemia. J Clin Oncol (2005) 2.04
Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience. J Clin Oncol (2004) 2.00
A disease risk index for patients undergoing allogeneic stem cell transplantation. Blood (2012) 2.00
Melanoma patients with positive sentinel nodes who did not undergo completion lymphadenectomy: a multi-institutional study. Ann Surg Oncol (2006) 2.00
Chemotherapy for metastatic melanoma: time for a change? Cancer (2007) 1.99
Memory regulatory T cells reside in human skin. J Clin Invest (2014) 1.95
Failure-free survival after second-line systemic treatment of chronic graft-versus-host disease. Blood (2013) 1.94
Multidisciplinary considerations in the implementation of the findings from the American College of Surgeons Oncology Group (ACOSOG) Z0011 study: a practice-changing trial. Ann Surg Oncol (2011) 1.93
Metastatic melanoma to lymph nodes in patients with unknown primary sites. Cancer (2006) 1.93
Role for intraoperative margin assessment in patients undergoing breast-conserving surgery. Ann Surg Oncol (2007) 1.92
Metastasectomy for distant metastatic melanoma: analysis of data from the first Multicenter Selective Lymphadenectomy Trial (MSLT-I). Ann Surg Oncol (2012) 1.92